Patient Reported Outcomes (PROs) as Part of Value-Based Care Can Shape Therapy Guidelines: Impact on Emerging Targeted Agents and Immunotherapy Protocols in Resource-Limited Regions
Crossref DOI link: https://doi.org/10.1007/s40487-016-0038-7
Published Online: 2017-01-05
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mott, Frank E. http://orcid.org/0000-0003-2963-5328